Parhofer, Klaus G.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Prevalence and sociodemographic determinants of adult obesity: a large representative household survey in a resource-constrained African setting with double burden of undernutrition and overnutrition

Chigbu, Chibuike Ogwuegbu, Parhofer, Klaus G, Aniebue, Uzochukwu U, Berger, Ursula

Journal:

Journal of Epidemiology & Community Health

Year:

2018

Language:

english

File:

PDF, 191 KB

english, 2018

2

Lipoprotein(a): Medical Treatment Options for an Elusive Molecule

G. Parhofer, Klaus

Journal:

Current Pharmaceutical Design

Year:

2011

Language:

english

File:

PDF, 106 KB

english, 2011

3

Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events

Jaeger, Beate R, Richter, Yvonne, Nagel, Dorothea, Heigl, Franz, Vogt, Anja, Roeseler, Eberhard, Parhofer, Klaus, Ramlow, Wolfgang, Koch, Michael, Utermann, Gerd, Labarrere, Carlos A, Seidel, Dietrich

Journal:

Nature Clinical Practice Cardiovascular Medicine

Year:

2009

Language:

english

File:

PDF, 209 KB

english, 2009

4

Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects

Hans C. Geiss, Carsten Otto, Peter Schwandt, Klaus G. Parhofer

Journal:

Year:

2001

Language:

english

File:

PDF, 101 KB

english, 2001

5

PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice

Parhofer, Klaus G., von Stritzky, Berndt, Pietschmann, Nicole, Dorn, Cornelia, Paar, W. Dieter

Journal:

Drugs - Real World Outcomes

Year:

2019

Language:

english

File:

PDF, 860 KB

english, 2019

6

“European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary

P. Mikhailidis, Dimitri, Elisaf, Moses, Rizzo, Manfredi, Berneis, Kaspar, Griffin, Bruce, Zambon, Alberto, Athyros, Vasilios, de Graaf, Jacqueline, Marz, Winfried, G. Parhofer, Klaus, Battista Rini, G

Journal:

Current Vascular Pharmacology

Year:

2011

Language:

english

File:

PDF, 30 KB

english, 2011

7

Die Verordnung von PCSK9-Inhibitoren ist klar geregelt; PCSK9 inhibitors: For which patients? For which indication? What to consider?;

Busygina, Kristina, Parhofer, Klaus G.

Journal:

MMW - Fortschritte der Medizin

Year:

2018

Language:

german

File:

PDF, 177 KB

german, 2018

8

Bowel habits and bile acid malabsorption in the months after cholecystectomy

Gerd H Sauter, Ahmed C Moussavian, Guenther Meyer, Heinrich O Steitz, Klaus G Parhofer, Dieter Jüngst

Journal:

American Journal of Gastroenterology

Year:

2002

Language:

english

File:

PDF, 62 KB

english, 2002

9

Atorvastatin Improves Postprandial Lipoprotein Metabolism in Normolipidemic Subjects 1

Parhofer, Klaus G., Barrett, P. Hugh R., Schwandt, Peter

Journal:

Journal of Clinical Endocrinology & Metabolism

Year:

2000

Language:

english

File:

PDF, 165 KB

english, 2000

10

Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a)

Waldmann, Elisa, Parhofer, Klaus G.

Journal:

Year:

2019

Language:

english

File:

PDF, 687 KB

english, 2019

11

Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivo

Jochen G Schneider, Max von Eynatten, Klaus G Parhofer, Jan E Volkmer, Stephan Schiekofer, Andreas Hamann, Peter P Nawroth, Klaus A Dugi

Journal:

Atherosclerosis

Year:

2004

Language:

english

File:

PDF, 81 KB

english, 2004

12

Head-to-head comparison of an automated immunometric and an automated HPLC method for the quantification of HbA1c

Michael Vogeser, Klaus G. Parhofer

Journal:

Clinical Biochemistry

Year:

2008

Language:

english

File:

PDF, 229 KB

english, 2008

13

So steuern Sie das Essverhalten Ihrer Patienten in die richtige Richtung

Lechner, Katharina, Parhofer, Klaus G.

Journal:

MMW - Fortschritte der Medizin

Year:

2016

Language:

german

File:

PDF, 515 KB

german, 2016

14

A Walnut-Enriched Diet Affects Gut Microbiome in Healthy Caucasian Subjects: A Randomized, Controlled Trial

Bamberger, Charlotte, Rossmeier, Andreas, Lechner, Katharina, Wu, Liya, Waldmann, Elisa, Fischer, Sandra, Stark, Renée, Altenhofer, Julia, Henze, Kerstin, Parhofer, Klaus

Journal:

Year:

2018

Language:

english

File:

PDF, 2.55 MB

english, 2018

15

Lipidstoffwechselstörungen und deren Behandlung bei Diabetes mellitus; Dyslipidemias and their treatment in diabetes mellitus;

Parhofer, Klaus G.

Journal:

Der Diabetologe

Year:

2019

Language:

german

File:

PDF, 135 KB

german, 2019

16

BMI and hyperinsulinemia in children

Michael Vogeser, Peter Schwandt, Gerda-Maria Haas, Uli C. Broedl, Michael Lehrke, Klaus G. Parhofer

Journal:

Clinical Biochemistry

Year:

2009

Language:

english

File:

PDF, 193 KB

english, 2009

17

Efficacy and Safety of a New Whole-blood Low-density Lipoprotein Apheresis System (Liposorber D) in Severe Hypercholesterolemia

Carsten Otto, Peter Kern, Rolf Bambauer, Stefan Kallert, Peter Schwandt, Klaus G. Parhofer

Journal:

Artificial Organs

Year:

2003

Language:

english

File:

PDF, 66 KB

english, 2003

18

Statine revolutionieren die kardiovaskuläre Prävention

Prof. Dr. med. Klaus G. Parhofer

Journal:

MMW - Fortschritte der Medizin

Year:

2008

Language:

german

File:

PDF, 196 KB

german, 2008

19

Statin intolerance is the main indication for PCSK9 inhibition in clinical practice

Waldmann, Elisa, Bamberger, Charlotte, Parhofer, Klaus G.

Journal:

Atherosclerosis

Year:

2017

Language:

english

File:

PDF, 47 KB

english, 2017

20

Zuckerkranke beim Hausarzt in guten Händen

Parhofer, Klaus G.

Journal:

MMW - Fortschritte der Medizin

Year:

2018

Language:

german

File:

PDF, 107 KB

german, 2018

21

Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review

Bruckert, Eric, Parhofer, Klaus Georg, Gonzalez-Juanatey, Jose Ramon, Nordestgaard, BÃ¸rge, Arca, Marcello, Giovas, Periklis, Ray, Kausik

Journal:

Advances in Therapy

Year:

2020

Language:

english

File:

PDF, 592 KB

english, 2020

22

Zufallsbefund Hypertriglyzeridämie

Parhofer, Klaus G.

Journal:

MMW - Fortschritte der Medizin

Year:

2015

Language:

german

File:

PDF, 132 KB

german, 2015

23

Cisplatin-Based Chemotherapy for Pulmonary Metastasized Germ Cell Tumors of the Testis – Be Aware of Acute Respiratory Distress Syndrome

Boeck, Stefan, Metzeler, Klaus H., Hausmann, Andreas, Baumann, Anja, Gallmeier, Eike, Parhofer, Klaus G., Stemmler, Hans-Joachim

Journal:

Year:

2009

Language:

english

File:

PDF, 121 KB

english, 2009

24

Sekundärdatenanalyse zur Ermittlung der Prävalenz von kardiovaskulären Hochrisiko-Patienten mit Hypercholesterinämie und therapierefraktärem Behandlungsverlauf

Dippel, Franz-Werner, Parhofer, Klaus, Müller-Bohn, Thomas, Gebhardt, Steffen, Kostev, Karel

Journal:

DMW - Deutsche Medizinische Wochenschrift

Year:

2017

File:

PDF, 232 KB

2017

25

HDL cholesterol: reappraisal of its clinical relevance

März, Winfried, Kleber, Marcus E., Scharnagl, Hubert, Speer, Timotheus, Zewinger, Stephen, Ritsch, Andreas, Parhofer, Klaus G., von Eckardstein, Arnold, Landmesser, Ulf, Laufs, Ulrich

Journal:

Clinical Research in Cardiology

Year:

2017

Language:

english

File:

PDF, 1.47 MB

english, 2017

26

THE EFFECT OF PCSK9 INHIBITION ON LDL-SUBFRACTIONS IN PATIENTS WITH SEVERE LDL-HYPERCHOLESTEROLEMIA

Wu, Liya, Bamberger, Charlotte, Waldmann, Elisa, Stark, Renee, Henze, Kerstin, Parhofer, Klaus

Journal:

Journal of the American College of Cardiology

Year:

2017

Language:

english

File:

PDF, 1.08 MB

english, 2017

27

THE EFFECT OF PCSK9 INHIBITION IN FAMILIAL DYSBETALIPOPROTEINEMIA (TYPE III HYPERLIPOPROTEINEMIA): 4 CASES

Busygina, Kristina, Waldmann, Elisa, Parhofer, Klaus

Journal:

Journal of the American College of Cardiology

Year:

2018

Language:

english

File:

PDF, 166 KB

english, 2018

28

LDL-Cholesterin: Die klar definierten Zielwerte ernst nehmen!; Lipidology — important changes of the last 10 years;

Parhofer, Klaus G.

Journal:

MMW - Fortschritte der Medizin

Year:

2018

Language:

german

File:

PDF, 194 KB

german, 2018

29

Statine nutzen auch gesunden Alten

Parhofer, Klaus Georg

Journal:

MMW - Fortschritte der Medizin

Year:

2020

File:

PDF, 130 KB

2020

30

Die neuen Standards in der Diabetologie

Parhofer, Klaus G.

Journal:

MMW - Fortschritte der Medizin

Year:

2012

Language:

german

File:

PDF, 127 KB

german, 2012

31

Current Role of Lipoprotein Apheresis

Thompson, Gilbert, Parhofer, Klaus G.

Journal:

Current Atherosclerosis Reports

Year:

2019

Language:

english

File:

PDF, 966 KB

english, 2019

32

Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap

Parhofer, Klaus G, Chapman, M John, Nordestgaard, BÃ¸rge G

Journal:

European Heart Journal Supplements

Year:

2020

File:

PDF, 686 KB

2020

33

Influence of Atorvastatin Versus Simvastatin on Fibrinogen and Other Hemorheological Parameters in Patients with Severe Hypercholesterolemia Treated with Regular Low-Density Lipoprotein Immunoadsorption Apheresis

Carsten Otto, H. Christian Geiss, Markus G. Donner, Klaus G. Parhofer, Peter Schwandt

Journal:

Therapeutic Apheresis and Dialysis

Year:

2000

Language:

english

File:

PDF, 192 KB

english, 2000

34

Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome

Uli C Broedl, Michael Lehrke, Elisabeth Fleischer-Brielmaier, Anne B Tietz, Jutta M Nagel, Burkhard Göke, Peter Lohse, Klaus G Parhofer

Journal:

Cardiovascular Diabetology

Year:

2006

Language:

english

File:

PDF, 523 KB

english, 2006

35

Grober Behandlungsfehler: Nachweislast liegt beim Arzt

Parhofer, Klaus G.

Journal:

MMW - Fortschritte der Medizin

Year:

2013

Language:

german

File:

PDF, 43 KB

german, 2013

36

Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia

Parhofer, Klaus

Journal:

Vascular Health and Risk Management

Year:

2009

File:

PDF, 193 KB

2009

37

Positionspapier zur Lipidtherapie bei Patienten mit Diabetes mellitus

Parhofer, Klaus, Birkenfeld, Andreas, Krone, Wilhelm, Lehrke, Michael, Marx, Nikolaus, Merkel, Martin, Schütt, Katharina, Zirlik, Andreas, Müller-Wieland, Dirk

Journal:

Diabetologie und Stoffwechsel

Year:

2018

Language:

german

File:

PDF, 1.50 MB

german, 2018

38

Drug Therapy of Severe Hypercholesterolemia in Patients with Coronary Artery Disease

Klaus G. Parhofer, Werner O. Richter, Peter Schwandt

Journal:

Artificial Organs

Year:

1996

Language:

english

File:

PDF, 618 KB

english, 1996

39

Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins

H. Christian Geiss, Carsten Otto, Klaus G. Parhofer

Journal:

Year:

2006

Language:

english

File:

PDF, 179 KB

english, 2006

40

Cardiac Output Measurements in Septic Patients: Comparing the Accuracy of USCOM to PiCCO

Horster, Sophia, Stemmler, Hans-Joachim, Strecker, Nina, Brettner, Florian, Hausmann, Andreas, Cnossen, Jitske, Parhofer, Klaus G., Nickel, Thomas, Geiger, Sandra

Journal:

Critical Care Research and Practice

Year:

2012

Language:

english

File:

PDF, 136 KB

english, 2012

41

Zielwerte erleichtern (auch) die Kommunikation

Parhofer, Klaus G.

Journal:

MMW - Fortschritte der Medizin

Year:

2019

Language:

german

File:

PDF, 182 KB

german, 2019

42

Extended-Release Niacin/Laropiprant Improves Overall Efficacy of Postprandial Reverse Cholesterol TransportSignificance

El Khoury, Petra, Waldmann, Elisa, Huby, Thierry, Gall, Julie, Couvert, Philippe, Lacorte, Jean-Marc, Chapman, John, Frisdal, Eric, Lesnik, Philippe, Parhofer, Klaus G., Le Goff, Wilfried, Guerin, Mar

Journal:

Arteriosclerosis Thrombosis and Vascular Biology

Year:

2016

Language:

english

File:

PDF, 1.31 MB

english, 2016

43

Reply to: “Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis: Corrections of the report on the randomized MICA-study”

Waldmann, Elisa, Vogt, Anja, Crispin, Alexander, Altenhofer, Julia, Riks, Ina, Parhofer, Klaus Georg

Journal:

Atherosclerosis

Year:

2018

Language:

english

File:

PDF, 130 KB

english, 2018

44

MedikamentÃ¶se Therapie von FettstoffwechselstÃ¶rungen bei Patienten mit Typ-2-Diabetes

MÃ¼ller-Wieland, Dirk, Parhofer, Klaus

Journal:

Gefäßmedizin Scan

Year:

2019

Language:

german

File:

PDF, 1.05 MB

german, 2019

45

Everyday Life, Dietary Practices, and Health Conditions of Adult PKU Patients: A Multicenter, Cross-Sectional Study

Klimek, Annemarie, Baerwald, Christoph, Schwarz, Martin, Rutsch, Frank, Parhofer, Klaus G., PlÃ¶ckinger, Ursula, Heddrich-Ellerbrok, Margret, vom Dahl, Stephan, SchÃ¶ne, Klaus, Ott, Markus, Lang, Frau

Journal:

Annals of Nutrition & Metabolism

Year:

2020

File:

PDF, 230 KB

2020

46

Metabolic syndrome predicts vascular changes in whole body magnetic resonance imaging in patients with long standing diabetes mellitus

Hannes M Findeisen, Sabine Weckbach, Renée G Stark, Maximilian F Reiser, Stefan O Schoenberg, Klaus G Parhofer

Journal:

Cardiovascular Diabetology

Year:

2010

Language:

english

File:

PDF, 936 KB

english, 2010

47

Neues von Cholesterin & Co

Parhofer, Klaus

Journal:

MMW - Fortschritte der Medizin

Year:

2016

Language:

german

File:

PDF, 654 KB

german, 2016

48

Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia

Parhofer, Klaus G.

Journal:

Diabetes & Metabolism Journal

Year:

2015

Language:

english

File:

PDF, 157 KB

english, 2015

49

Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia

Carsten Otto, Jutta Berster, Bärbel Otto, Klaus G. Parhofer

Journal:

Journal of Clinical Apheresis

Year:

2007

Language:

english

File:

PDF, 98 KB

english, 2007

50

Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study

Klaus G Parhofer, Felix Münzel, Michael Krekler

Journal:

Cardiovascular Diabetology

Year:

2007

Language:

english

File:

PDF, 493 KB

english, 2007

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски